“Their will. Our medicines. Together We can prevail.“ As you may know, this is the global theme for the Bristol-Myers Squibb Company. We at Bristol-Myers Squibb Japan are strongly aligned to the core idea behind this theme – that we work every day in support of the patients who can benefit from our medicines. In our everyday work from research and development, manufacturing to sales activities, as a pharmaceutical company, we always think first about the patients.

Our corporate strategy is to transform ourselves into a “next generation bio pharma company”. This is a unique combination of traditional big pharma’s expertise and innovative bio technology company. A key part of that strategy is to focus on the right priorities and choices that help us bring innovative new medicines to patients as soon as possible. We share the passion and commitment to making that happen here in Japan.

What new direction does this strategy take us in Japan? Bristol-Myers K.K. continues to grow in Japan having clear business visions that are to accelerate product development process in order to introduce new drugs continuously and to extend its focusing disease areas where still have to fulfill the unmet medical needs. Last three years, we have launched three new products; one is for hepatitis B and two are for cancer. We also have several potential products in our pipelines, which will strongly complement our existing product lineup. In addition to the fact that we now have strength and experience in oncology and hepatitis; we intend to continue to expand our focusing disease areas to, rheumatoid arthritis, diabetes, and Alzheimer's disease so that patients and medical professions who fight against those diseases will have access to those new drugs.

Of special note, 2010 markets the 50th anniversary of Bristol-Myers Squibb in Japan. Over those 50 years, we have shown our strong commitment to all Japanese stakeholders including hospitals, doctors and patients in the society. Each day forward, our nearly one thousand will continue to dedicate themselves to their day-to-day work that will help to make a difference in patients’ lives. After all, this is the very spirit of the company theme: “Together we can prevail”.

President & CEO
Emmanuel Blin

日本語のメッセージはこちら